Everybody agreed on the importance of this conference. It was vibrant, thought provoking and motivating. How can we change things? For a better future? Three visions.
Paulien Bongers, Organisation for Applied Scientific Research(TNO), The Netherlands
The future in monitoring and management of carcinogens:
• New emerging technologies allow a better understanding of risk and effect.
• Open the gate to a real time personalized assessment and more direct and targeted management.
• Make early warning systems more widely available, which allow for better protection and pro-active management.
• Digitalization should lead to the necessary integrated information on what to do for all stakeholders.
• Effective management is an integrated effort (personalized and contextual) which is embedded in the culture and core business of companies.
• Regulators can actively incorporate validated practices in their policies to make the best practice the easy practice.
Director of the European Agency
for Safety and Health at Work
Establishing a Prevention Culture on Dangerous Substances
• Translating information for the workplace level, in particular SMEs
• Encouraging communication up and down the supply chain
• Reinforcing the substitution principle and hierarchy of control measures
• Analysing and sharing information on newly developed tools and instruments
• Addressing changes in chemical legislation and consequences for workplaces:
• How REACH and CLP contribute to information
• Consider biological agents, substances generated by work, and not under CLP
• Addressing changes: new risks (e.g. nanomaterials), combined risks, changes in work, sectors and workforce
• Addressing issues relevant to vulnerable workers
• Addressing gender issues
Michel Servoz, Director-General Employment, Social Affairs and Inclusion, European Commission
European Commission on Policy and future steps
"First priority: for the council and the parliament to adopt our carcinogens proposal. I hope we can get an agreement quickly on the values as have been set by the commission.
Second priority: to continue the work on carcinogens. We've started to prepare a second batch of exposure limit values for carcinogens, which should be ready by the end of the year. We’ll look even further and examine whether a third batch would deserve to be set as exposure limit values in the future.
Third priority: we aim to restore the engine for upward convergence in the European Union that has been damaged by the economic crisis. Health and Safety issues are one of the key elements.
Fourth priority: Implementation is very important. We need to take some action to reduce the burden on companies, and to help them improve their implementation."